
Juvenile idiopathic arthritis (JIA) is the name for a group of chronic inflammatory conditions that cause arthritis in children under the age of 16. It is the most common form of arthritis in children and one of the most common chronic childhood illnesses in Australia.
The name reflects three key features of the condition:
JIA is an autoimmune condition, meaning the immune system mistakenly attacks the body's own joint tissues, causing ongoing inflammation, pain, and swelling. There are several different subtypes of JIA, each with its own pattern of joint involvement and set of symptoms.
The outlook for children with JIA has improved significantly. With early diagnosis and appropriate treatment, many children with JIA will go into remission – sometimes permanently – and most will not have active symptoms by the time they reach adulthood.
At least 5,000 children in Australia are living with JIA at any one time, with a prevalence of approximately 1 to 4 per 1,000 children. This makes JIA roughly as common as childhood diabetes in Australia.
JIA can develop at any age under 16 and affects both boys and girls, though rates vary by subtype. Some subtypes are more common in girls, while others such as enthesitis-related arthritis are more common in boys.
Symptoms vary depending on the subtype of JIA and the child, and can fluctuate between flares (periods of worsening) and remission (periods of reduced or no symptoms). Common symptoms include:
JIA symptoms can be easy to miss or mistake for growing pains. If a child has joint swelling or persistent pain lasting more than six weeks, they should be assessed by a doctor.
The exact cause of JIA is not known. It is thought to involve:
JIA is not contagious and cannot be passed from one child to another.
There is no single test for JIA. Diagnosis involves a combination of:
If JIA is suspected, your child's GP should refer them to a paediatric rheumatologist – a specialist in childhood arthritis. Reaching a diagnosis can take time due to the fluctuating nature of JIA, but early referral and diagnosis leads to significantly better outcomes.
Treatment aims to reduce inflammation, relieve symptoms, protect joints, and support the child's normal growth and development. Management involves a multidisciplinary team including a rheumatologist, physiotherapist, occupational therapist, ophthalmologist, and often a psychologist or school support worker.
Exercise and physical activity: Regular physical activity is essential and strongly encouraged. Low-impact activities such as swimming, cycling, and yoga are ideal. An individually tailored physiotherapy program can help maintain joint mobility and muscle strength.
Self-management and family support: Pain management techniques including heat and cold therapy, relaxation, and gentle stretching can help between medical appointments. Children with JIA should be supported to participate in school and social activities as normally as possible.
NSAIDs (non-steroidal anti-inflammatory drugs) such as ibuprofen or naproxen are used for pain and inflammation relief in mild cases. Corticosteroid injections into specific inflamed joints can provide significant short-term relief, particularly in oligoarthritis.
Conventional DMARDs (disease-modifying anti-rheumatic drugs) are typically the first step when NSAIDs are insufficient. Methotrexate is the most commonly used option and is effective across several JIA subtypes; others include hydroxychloroquine and sulfasalazine.
When conventional DMARDs haven't adequately controlled disease, biologic DMARDs are used. These target specific parts of the immune system and must be prescribed by a specialist. Types include TNF inhibitors, IL-6 inhibitors, and T-cell inhibitors.
JAK inhibitors (Janus kinase inhibitors) are a newer class of oral medications targeting specific immune pathways, used when other treatments have been insufficient.
The following specialty medications are available at Ace, a specialty pharmacy for Juvenile Idiopathic Arthritis.
Biosimilars of adalimumab and etanercept are available on the PBS. Speak with your Ace pharmacist about your options.
With Ace, you’ll benefit from:
Take control of your health and well-being, and start your journey to better health with Ace today.
There are many organisations that support Australian children and families living with JIA.